A review of PD-1/PD-L1 siRNA delivery systems in immune T cells and cancer cells.

导出 LinkOut

翻译打印收藏纠错

作者： Mehdi,Barati ^[1] ; Farshad,Mirzavi ^[2] ; Mahdi,Atabaki ^[3] ; Bahram,Bibak ^[4] ; Mojgan,Mohammadi ^[5] ; Mahmoud Reza,Jaafari ^[6]

作者单位： Department of Pathobiology and Laboratory Sciences, North Khorasan University of Medical Sciences, Bojnurd, Iran. ^[1] Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran. ^[2] Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. ^[3] Department of Physiology, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran. ^[4] Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. ^[5] Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: JafariMR@mums.ac.ir. ^[6]

关键词 Cancer cells Immune cells Program death 1 Small interfering RNA

主题词细胞系, 肿瘤(Cell Line, Tumor);配体(Ligands);肿瘤(Neoplasms);RNA, 小分子干扰(RNA, Small Interfering);T淋巴细胞(T-Lymphocytes)

DOI 10.1016/j.intimp.2022.109022

PMID 35987146

发布时间 2022-09-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交